Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

January 31, 2007

Conditions
Dermatitis, Atopic
Interventions
DRUG

Pimecrolimus plus topical corticosteroid (TCS)

Pimecrolimus 1 % cream plus topical corticosteroid (TCS) twice daily

DRUG

Pimecrolimus vehicle (Placebo) plus topical corticosteroid (TCS)

twice daily administration

Trial Locations (13)

19104

Children's Hospital of Philadelphia, Philadelphia

23298

Virginia Commonwealth University, Richmond

27157

Wake Forest University School of Medicine Dept. of Dermatology, Winston-Salem

30912

Medical College of Georgia - Clinical Investigative Services, Augusta

33134

Dermatology Associates and Research, Coral Gables

38018

520 Trinity Creek Cove, Cordova

80206

National Jewish Medical and Research Center, Denver

92123

Children's Hospital -San Diego, San Diego

92647

Pediatric Care Medical Group, Inc., Huntington Beach

97030

Calcagno Research and Development, Gresham

98105

A.S.T.H.M.A., Inc, Seattle

03756

Dartmouth Hitchcock Medical Center Section of Dermatology, Lebanon

02903

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY